venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 6
- −1 vs. Q1 2025
- Portfolio value
- $114.8M
- −$8.80M (−7.1%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | COM | 4,289,304 | $75.5M | 65.8% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 489,194 | $15.5M | 13.5% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 4,619,803 | $13.9M | 12.1% | +1,832,405+65.7% | Added | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 473,479 | $4.19M | 3.6% | +118,370+33.3% | AddedConverted for a 1-for-20 split | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $4.03M | 3.5% | 00.0% | Unchanged | History |
| ARTVArtiva Biotherapeutics, Inc. | COM | 1,148,975 | $1.73M | 1.5% | −50,000−4.2% | Reduced | History |
Sold out since Q1 2025 (1)
Positions held at the end of Q1 2025 that are gone from this filing.